Naoko Hosono

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Therapeutic strategies for older adults with acute myeloid leukemia

Therapeutic strategies for older adults with acute myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.

Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.

Journal: Biochemical pharmacology

Published: May 07, 2026

Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview.

Japanese clinical practice guidelines for pharmacotherapy in older adults with cancer (second edition): an overview.

Journal: International journal of clinical oncology

Published: May 02, 2026

Timing of response in patients with relapsed/refractory FLT3 mut+ acute myeloid leukemia treated with gilteritinib.

Timing of response in patients with relapsed/refractory FLT3 mut+ acute myeloid leukemia treated with gilteritinib.

Journal: Blood neoplasia

Published: February 19, 2026

The new era of AML therapy: current standards and emerging targets.

The new era of AML therapy: current standards and emerging targets.

Journal: International journal of clinical oncology

Published: February 18, 2026

SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

SCRUM-Japan MONSTAR3 hematology cohort: a nationwide multi-omics integrated platform for next-generation precision medicine in hematologic malignancies.

Journal: International journal of clinical oncology

Published: February 12, 2026

Acute myeloid leukemia therapy in the era of comprehensive genomic profiling

Acute myeloid leukemia therapy in the era of comprehensive genomic profiling

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 05, 2025

Targeting drug efflux and DNA repair enhances inotuzumab ozogamicin activity in IO-resistant B-ALL cell lines.

Targeting drug efflux and DNA repair enhances inotuzumab ozogamicin activity in IO-resistant B-ALL cell lines.

Journal: International journal of hematology

Published: September 19, 2025

Adult-onset Vitamin K-dependent Coagulation Factor Deficiency of Unidentified Etiology.

Adult-onset Vitamin K-dependent Coagulation Factor Deficiency of Unidentified Etiology.

Journal: Internal medicine (Tokyo, Japan)

Published: September 10, 2025

Adult-onset Vitamin K-dependent Coagulation Factor Deficiency of Unidentified Etiology.

Adult-onset Vitamin K-dependent Coagulation Factor Deficiency of Unidentified Etiology.

Journal: Internal medicine (Tokyo, Japan)

Published: September 10, 2025

Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

Journal: British journal of haematology

Published: April 18, 2025

Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study.

Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study.

Journal: International journal of hematology

Published: April 04, 2025

Showing 1-12 of 76

Last Updated: 09/26/2026